KardioVis srl

KardioVis has developed a portable, connected medical device that integrates advanced sensors and AI-based analytics to support the early identification of signs of cardiac function deterioration—potentially up to four weeks before the onset of heart failure symptoms.

The device is simple, fast, and non-invasive: it can be placed directly on the patient’s chest without the need to undress or undergo specific training, enabling the collection of standardized, clinically relevant cardiac signals in just a few seconds, also suitable for remote monitoring settings.

By analyzing functional parameters over time, the KardioVis platform provides physicians with structured insights to support more timely management of at-risk patients, with the aim of detecting early stages of clinical deterioration that often precede hospitalizations—known for their significant impact on mortality, quality of life, and healthcare costs.

For patients, the system enables continuous, non-invasive monitoring from the comfort of home; for healthcare systems and insurers, it paves the way for a more predictive care model, with the potential to reduce hospitalizations and associated costs related to heart failure.